Injectable pharmaceutical compositions and their uses

ES2969653T5Active Publication Date: 2026-07-14INTERVET INT BV
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
ES · ES
Patent Type
Patents
Current Assignee / Owner
INTERVET INT BV
Filing Date
2021-05-19
Publication Date
2026-07-14

AI Technical Summary

Technical Problem

There is a need for a long-acting injectable veterinary pharmaceutical composition that can provide effective and prolonged protection against parasites such as fleas, ticks, mites, and helminths in pets with a single injection, while addressing issues of rapid release hampered by poor water solubility and ensuring stability and safety of active ingredients.

Method used

An injectable veterinary composition comprising microspheres of physiologically active macrocyclic lactones and isoxazoline compounds suspended in an aqueous carrier, with specific particle sizes and ratios, to achieve prolonged plasma levels and stable, effective release.

Benefits of technology

The composition provides long-lasting activity, stable content, and safe administration with minimal side effects, ensuring high bioavailability and effective plasma levels of both macrocyclic lactones and isoxazoline compounds.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 00000034_0000
    Figure 00000034_0000
  • Figure 00000035_0000
    Figure 00000035_0000
  • Figure 00000036_0000
    Figure 00000036_0000
Patent Text Reader

Abstract

The present invention relates to injectable compositions comprising the combination of an isoxazoline compound as well as a physiologically active macrocyclic lactone such as moxidectin.
Need to check novelty before this filing date? Find Prior Art